• 1. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Professional Introduction to Cypenamine (CAS No. 6604-06-4)

Cypenamine, a compound with the chemical name (E)-1-(4-fluorophenyl)-3-(1-pyrrolidinyl)acrylamide, is a significant molecule in the field of pharmaceutical chemistry and biochemistry. Its unique structure and biological properties have garnered considerable attention from researchers worldwide. The CAS No. 6604-06-4 uniquely identifies this compound, ensuring precise classification and communication within the scientific community.

The molecular formula of Cypenamine is C??H??FN?O?, reflecting its complex and multifaceted composition. This compound belongs to the class of amides, which are widely recognized for their diverse biological activities. The presence of both aromatic and heterocyclic rings in its structure contributes to its remarkable chemical stability and reactivity, making it a valuable candidate for further investigation in drug development.

Recent advancements in medicinal chemistry have highlighted the potential of Cypenamine as a lead compound for therapeutic applications. Studies have demonstrated its efficacy in modulating various biological pathways, particularly those involved in neurodegenerative diseases. The fluorophenyl moiety in its structure plays a crucial role in enhancing binding affinity to target proteins, thereby improving its pharmacological profile.

One of the most intriguing aspects of Cypenamine is its interaction with neurotransmitter receptors. Research has shown that it can selectively bind to certain serotonin receptors, which are implicated in mood regulation and cognitive functions. This property makes it a promising candidate for the development of novel antidepressants and anxiolytics. Furthermore, its ability to cross the blood-brain barrier enhances its potential as a central nervous system (CNS) therapeutic agent.

The synthesis of Cypenamine involves multi-step organic reactions, including condensation, fluorination, and cyclization processes. These synthetic pathways have been optimized to ensure high yield and purity, which are critical for pharmaceutical applications. The compound’s stability under various storage conditions further adds to its practicality as a research tool and potential drug candidate.

Investigations into the pharmacokinetics of Cypenamine have revealed interesting insights into its absorption, distribution, metabolism, and excretion (ADME) profiles. These studies have been instrumental in understanding how the compound behaves within the body and how it can be optimized for better therapeutic efficacy. Additionally, computational modeling techniques have been employed to predict potential side effects and interactions with other drugs.

The latest research findings on Cypenamine have opened new avenues for therapeutic intervention in neurological disorders. For instance, preclinical studies have demonstrated its potential in mitigating symptoms associated with Alzheimer’s disease by inhibiting beta-amyloid aggregation. This mechanism of action aligns with current trends in neurodegenerative disease treatment, where targeting protein misfolding is a key strategy.

Another area where Cypenamine shows promise is in the treatment of chronic pain syndromes. Its ability to modulate pain signaling pathways has been observed in both animal models and human cell cultures. This suggests that it could be a valuable adjunct therapy for conditions such as neuropathic pain and fibromyalgia, where conventional treatments often fall short.

The role of Cypenamine in anti-inflammatory applications cannot be overstated either. Inflammatory processes are central to many diseases, including autoimmune disorders and cardiovascular conditions. By interacting with inflammatory mediators and cytokines, Cypenamine has shown promise in reducing inflammation without compromising immune function.

As research continues to unfold, the therapeutic potential of Cypenamine is likely to expand further. The development of novel derivatives with enhanced properties is an active area of investigation among pharmaceutical companies and academic researchers alike. These derivatives aim to improve solubility, bioavailability, and target specificity while maintaining or even enhancing the biological activity of the parent compound.

The regulatory landscape for Cypenamine is also evolving rapidly. As more data becomes available on its safety and efficacy, regulatory agencies are likely to provide clearer guidelines for its clinical development. This progress bodes well for future clinical trials and eventual market approval as a therapeutic agent.

In conclusion, Cypenamine (CAS No. 6604-06-4) represents a significant advancement in pharmaceutical chemistry with broad therapeutic implications. Its unique structure, combined with promising preclinical data, positions it as a compelling candidate for further research and development. As scientists continue to explore its potential applications across various disease areas, Cypenamine is poised to make substantial contributions to modern medicine.

• 40264-04-8((1S,2S)-2-phenylcyclopentan-1-amine)
• 5588-23-8(2-phenylcyclopentanamine hydrochloride (1:1))
• 676464-29-2(Cyclopentanamine, 2-phenyl-, (1S,2R)-)
• 676464-31-6(Cyclopentanamine, 2-phenyl-, (1S,2S)-)
• 39550-30-6(3-phenylbicyclo2.2.1heptan-2-amine)
• 15301-54-9(2-phenylcyclopentanamine)
• 40297-12-9((1R,2S)-2-phenylcyclopentan-1-amine hydrochloride)
• 102778-42-7(Cyclopentanamine, 2-phenyl-, hydrochloride, (1S-cis)-)
• 17293-44-6(2-phenylcyclobutan-1-amine)
• 28051-94-7((2R,3S)-3-Phenylbicyclo[2.2.1]heptan-2-aMine)